Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Heritage Fiberall ads

This article was originally published in The Tan Sheet

Executive Summary

"They did it!" spokesperson Shirley Jones proclaims. "Now there's an easy, great-tasting way to stay regular and, with a low-fat diet, it helps your cholesterol and may even reduce your risk of heart disease" in ads beginning in late August. Jones is best known for the movies "Carousel," "Oklahoma" and "The Music Man," as well as the television show "The Partridge Family." Fiberall began shipping in April ("The Tan Sheet" April 20, p. 5). The label states that "Fiberall promotes normal regularity" and that "when used as part of a low fat diet, gives your body more of what it needs to lower cholesterol"; both statements bear the FDA disclaimer for dietary supplements. In addition to psyllium, oat fiber and oat bran, the product contains guar gum, gum Arabic, soy fiber and fruit pectin...

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088618

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel